1989
DOI: 10.1016/0223-5234(89)90052-4
|View full text |Cite
|
Sign up to set email alerts
|

New formulation of blood substitutes: optimization of novel fluorinated microemulsions

Abstract: The synthesis of a nove! microemulsion system composed of a mixed fluorinated and hydrogenated oil C 8 F 17-CH 2 CH=CH-C 4 H 9 with a biocompatible hydrogenated surfactant, Montanox 80 is described. Investigation of the solubility of oxygen in these microemulsions showed that they absorbed more oxygen than Fluosol-DA which is currently used as an oxygen transporter in biomedical applications. Oxygen absorption was similar to that of blood. Light scattering studies showed that the system was composed of small s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

1991
1991
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 12 publications
0
13
0
Order By: Relevance
“…Mass spectrometric studies on a series of partially fluorinated alkanes have confirmed their great stability [2]. The main applications for triblock and diblock semifluorinated n-alkanes ranging from biomedical field, as oxygen-carrying agents for blood substitutes [3][4][5][6][7][8], ophthalmology applications [9][10][11][12][13], perfluorocarbons emulsion stabilization [14,15], to applications as solid lubricants.…”
Section: Introductionmentioning
confidence: 99%
“…Mass spectrometric studies on a series of partially fluorinated alkanes have confirmed their great stability [2]. The main applications for triblock and diblock semifluorinated n-alkanes ranging from biomedical field, as oxygen-carrying agents for blood substitutes [3][4][5][6][7][8], ophthalmology applications [9][10][11][12][13], perfluorocarbons emulsion stabilization [14,15], to applications as solid lubricants.…”
Section: Introductionmentioning
confidence: 99%
“…6 It has also been reported that the ME structure plays an important role in drug release. [7][8][9][10] Over the last decade, a large number of studies on the ME systems available for pharmaceutical application has been published. 4,5,7,[11][12][13][14][15] These systems involve the use of biocompatible components with the ability to improve the solubility of sparing soluble drugs.…”
Section: Introductionmentioning
confidence: 99%
“…4,5,7,[11][12][13][14][15] These systems involve the use of biocompatible components with the ability to improve the solubility of sparing soluble drugs. 8,9,[16][17][18] Soy phosphatidylcholine (SPC) is a widely used biocompatible surfactant of natural origin from a component of cell membranes and is a known pharmaceutical ingredient that can be used for all administration routes including i.v. 1,19,20 In addition, monounsaturated fatty acids, such as oleic acid, have received increasing attention as penetration enhancers.…”
Section: Introductionmentioning
confidence: 99%
“…The latter showed that microemulsions of fluorocarbons could be obtained with a single, monodisperse, neutral perfluoroalkylpolyoxyethylene surfactant, but biocompatibility was not achieved. Rico and Lattes [117] have circumvented the difficulty of finding a sufficiently biocompatible fluorinated surfactant. Instead of adapting the surfactant to the fluorocarbon, they adapted the carrier molecule to the surfactant.…”
Section: New Emulsions With Improved Stabilitymentioning
confidence: 99%